Abstract
The effect of blockade of NF-kappaB activity on human pancreatic cancer angiogenesis was determined in an orthotopic xenograft model. Highly metastatic L3.3 human pancreatic cancer cells, which expressed an elevated level of constitutive NF-kappaB activity, were transfected with a mutated IkappaBalpha (IkappaBalphaM). After implantation in the pancreas of nude mice, parental (L3.3) and control vector-transfected (L3.3-Neo) cells produced rapidly growing tumors and liver metastases, whereas IkappaBalphaM-transfected (L3.3-IkappaBalphaM) cells had decreased tumorigenicity and metastatic potential. NF-kappaB signaling blockade significantly inhibited the in vitro and in vivo expression of the major proangiogenic molecules vascular endothelial growth factor and interleukin-8 and decreased tumor vascular formation. These events were correlated with retarded tumor growth and suppression of metastasis. Collectively, these data suggest that suppression of tumorigenicity and metastasis by NF-kappaB blockade is due to impaired angiogenic potential of tumor cells.
Copyright 2003 Wiley-Liss, Inc.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Humans
-
I-kappa B Proteins / genetics
-
I-kappa B Proteins / metabolism
-
Interleukin-8 / antagonists & inhibitors
-
Interleukin-8 / genetics
-
Interleukin-8 / metabolism
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Mutation
-
NF-KappaB Inhibitor alpha
-
NF-kappa B / antagonists & inhibitors*
-
NF-kappa B / physiology
-
Neoplasms, Experimental / blood supply*
-
Neoplasms, Experimental / metabolism
-
Neoplasms, Experimental / prevention & control
-
Neovascularization, Pathologic / metabolism*
-
Neovascularization, Pathologic / prevention & control
-
Pancreatic Neoplasms / blood supply*
-
Pancreatic Neoplasms / metabolism
-
Pancreatic Neoplasms / pathology
-
Promoter Regions, Genetic
-
Signal Transduction / physiology
-
Transfection
-
Tumor Cells, Cultured
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / genetics
-
Vascular Endothelial Growth Factor A / metabolism
-
Xenograft Model Antitumor Assays
Substances
-
I-kappa B Proteins
-
Interleukin-8
-
NF-kappa B
-
NFKBIA protein, human
-
Nfkbia protein, mouse
-
Vascular Endothelial Growth Factor A
-
NF-KappaB Inhibitor alpha